Bioverge Access Fund - Franklin, a Series of Bioverge Funds II, LLC — Form D/A
Bioverge Access Fund - Franklin, a Series of Bioverge Funds II, LLC of SALT LAKE CITY, UT, a pooled investment fund, filed a Form D amendment with the SEC on 2020-01-22. The offering totals $67K, of which $67K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-01-22
- Form: D/A
- Accession: 0001784623-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $67K
- Amount sold: $67K
- Minimum investment: $10K
- Investors: 6
- Date of first sale: 2019-11-18
- Security types: fund interests
- SEC file number: 021-354792
Issuer
- Name: Bioverge Access Fund - Franklin, a Series of Bioverge Funds II, LLC
- CIK: 0001784623
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6510 S Millrock Drive, SALT LAKE CITY, UT, 84121
- Phone: 8014190677
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Richard Thoms | Executive Officer | Salt Lake City, UT |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
Other filings by this issuer (2)
More